FDA Inspection 1219574 — Qilu Pharmaceutical Hulun Buir Branch
The FDA completed an inspection of Qilu Pharmaceutical Hulun Buir Branch on Aug 25, 2023 in Hulun Beier. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Veterinary.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 25, 2023
- Fiscal Year
- 2023
- Product Type
- Veterinary
- Project Area
- Pre-Approval Eval. of Animal Drugs and Food Additives
- Location
- Hulun Beier (China)